Subscribe To Our Free Newsletter |
Jubilant Pharmova declines after US FDA issues 3 observations to Washington-based facility
Jubilant Pharmova slipped 2.45% to Rs 739.70 after the United States Food and Drug Administration (US FDA) issued 3 observations post the completion of audit of Washington-based manufacturing facility of its step-down subsidiary.